JPH11124372A5 - - Google Patents

Info

Publication number
JPH11124372A5
JPH11124372A5 JP1998224015A JP22401598A JPH11124372A5 JP H11124372 A5 JPH11124372 A5 JP H11124372A5 JP 1998224015 A JP1998224015 A JP 1998224015A JP 22401598 A JP22401598 A JP 22401598A JP H11124372 A5 JPH11124372 A5 JP H11124372A5
Authority
JP
Japan
Prior art keywords
isopropanol
filtrate
cooling
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1998224015A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11124372A (ja
Filing date
Publication date
Priority claimed from DE19734438A external-priority patent/DE19734438A1/de
Priority claimed from DE1997156093 external-priority patent/DE19756093A1/de
Application filed filed Critical
Publication of JPH11124372A publication Critical patent/JPH11124372A/ja
Publication of JPH11124372A5 publication Critical patent/JPH11124372A5/ja
Pending legal-status Critical Current

Links

JP10224015A 1997-08-08 1998-08-07 Ｎ−（４−トリフルオロメチルフェニル）−５−メチルイソオキサゾール−４−カルボキサミドの結晶形態 Pending JPH11124372A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19734438A DE19734438A1 (de) 1997-08-08 1997-08-08 Kristallform von N-(4-Trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid
DE1997156093 DE19756093A1 (de) 1997-12-17 1997-12-17 Verfahren zur Herstellung einer Kristallform von N-(4-Trifluormethylphenyl)-5-methyl-isoxazole-4-carboxamid
DE19734438:0 1997-12-17
DE19756093:8 1997-12-17

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009175137A Division JP2009280604A (ja) 1997-08-08 2009-07-28 Ｎ−（４−トリフルオロメチルフェニル）−５−メチルイソオキサゾール−４−カルボキサミドの結晶形態の製造方法

Publications (2)

Publication Number Publication Date
JPH11124372A JPH11124372A (ja) 1999-05-11
JPH11124372A5 true JPH11124372A5 (https=) 2005-10-27

Family

ID=26038983

Family Applications (2)

Application Number Title Priority Date Filing Date
JP10224015A Pending JPH11124372A (ja) 1997-08-08 1998-08-07 Ｎ−（４−トリフルオロメチルフェニル）−５−メチルイソオキサゾール−４−カルボキサミドの結晶形態
JP2009175137A Pending JP2009280604A (ja) 1997-08-08 2009-07-28 Ｎ−（４−トリフルオロメチルフェニル）−５−メチルイソオキサゾール−４−カルボキサミドの結晶形態の製造方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009175137A Pending JP2009280604A (ja) 1997-08-08 2009-07-28 Ｎ−（４−トリフルオロメチルフェニル）−５−メチルイソオキサゾール−４−カルボキサミドの結晶形態の製造方法

Country Status (28)

Country Link
US (5) US6060494A (https=)
EP (2) EP0903345B1 (https=)
JP (2) JPH11124372A (https=)
KR (2) KR100544041B1 (https=)
CN (2) CN1181064C (https=)
AR (1) AR015418A1 (https=)
AT (2) ATE196764T1 (https=)
AU (1) AU752764B2 (https=)
BR (1) BR9806568A (https=)
CA (1) CA2245267C (https=)
CZ (3) CZ301514B6 (https=)
DE (2) DE59800287D1 (https=)
DK (2) DK0987256T3 (https=)
ES (2) ES2150808T3 (https=)
GR (1) GR3034814T3 (https=)
HK (1) HK1049481B (https=)
HU (2) HU225870B1 (https=)
ID (1) ID20667A (https=)
IL (1) IL125671A (https=)
NO (1) NO310871B1 (https=)
NZ (1) NZ331270A (https=)
PL (1) PL192126B1 (https=)
PT (2) PT903345E (https=)
RU (1) RU2224753C2 (https=)
SK (2) SK282641B6 (https=)
TR (2) TR199801513A3 (https=)
TW (1) TW593288B (https=)
UA (1) UA54411C2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903345B1 (de) * 1997-08-08 2000-10-04 Aventis Pharma Deutschland GmbH Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid
DE19908527C2 (de) 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
CN1411373A (zh) 1999-12-16 2003-04-16 特瓦制药工业有限公司 制备来氟米特的新方法和新晶形的来氟米特
ES2237553T3 (es) * 2000-02-15 2005-08-01 Teva Pharmaceutical Industries Ltd. Procedimiento para la sintesis de leflunomida.
EP1340749A4 (en) * 2000-11-17 2007-09-05 Takeda Pharmaceutical ISOXAZOLE DERIVATIVES
GB0123571D0 (en) 2001-04-05 2001-11-21 Aventis Pharm Prod Inc Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluoromethylphenyl)-amide for treating multiple sclerosis
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US20050158371A1 (en) * 2002-02-12 2005-07-21 Sumitomo Pharmaceuticals Co., Ltd. Novel external agent
WO2003068239A1 (en) * 2002-02-12 2003-08-21 Sumitomo Pharmaceuticals Co., Ltd. Novel drugs for external use
US20060135547A1 (en) * 2003-03-12 2006-06-22 Toth Zoltan G Stable pharmaceutical compositions of desloratadine and processes for preparation of polymorphic forms of desloratadine
ATE352305T1 (de) * 2003-03-12 2007-02-15 Teva Pharma Stabile pharmazeutische zusammensetzungen mit desloratadine
JP4223428B2 (ja) * 2004-03-31 2009-02-12 富士通メディアデバイス株式会社 フィルタおよびその製造方法
WO2007067710A1 (en) * 2005-12-08 2007-06-14 Amphora Discovery Corporation Certain chemical entities, compositions, and methods for modulating trpv1
CN101143834B (zh) * 2006-09-15 2010-09-08 欣凯医药化工中间体（上海）有限公司 N-(4-三氟甲基苯)-2-氰基-3-羟基丁烯酰胺钠盐的多晶型及其制备方法
EA017064B1 (ru) * 2008-03-10 2012-09-28 Такеда Фармасьютикал Компани Лимитед Кристаллическое производное бензимидазола
NZ598744A (en) 2009-09-18 2013-11-29 Sanofi Sa (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability
CN103977594B (zh) * 2014-06-03 2016-02-17 江苏九九久科技股份有限公司 一种结晶方法
US9895370B2 (en) * 2015-11-19 2018-02-20 Pharmedix.Co., Ltd Pharmaceutical composition for preventing or treating of cirrhosis of liver comprising G protein coupled receptor 119 ligand as an active ingredient
CN109180599A (zh) * 2018-09-03 2019-01-11 深圳市新阳唯康科技有限公司 一种来氟米特新晶型化合物及其制备方法
CN112898215B (zh) * 2021-02-04 2022-11-08 美罗药业股份有限公司 一种来氟米特晶型i的制备方法
CN114716388B (zh) * 2021-11-04 2024-02-13 江苏冠军科技集团股份有限公司 一种磺胺-银化合物及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES448386A1 (es) * 1975-06-05 1978-04-16 Hoechst Ag Procedimiento para la preparacion de anilidas de acido 5-me-til-isoxazol-4-carboxilico.
DE2524959C2 (de) * 1975-06-05 1983-02-10 Hoechst Ag, 6000 Frankfurt 5-Methyl-isoxazol-4-carbonsäureanilide, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Mittel
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DE2525959A1 (de) * 1975-06-11 1977-02-10 Focke Pfuhl Verpack Automat Verpackung fuer zigaretten, zigarillos etc.
DE2854439A1 (de) * 1978-12-16 1980-07-03 Hoechst Ag Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung
IL63968A (en) * 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
US4935434A (en) * 1988-01-26 1990-06-19 Bristol-Myers Company Antiarthritic isoxazole-4-carboxamides
US5583150A (en) * 1989-08-18 1996-12-10 Alcon Laboratories, Inc. 5-methyl-isoxazole-4-carboxylic acid anilides and 2-hydroxyethylidene-cyano acetic anilides for the treatment of ocular diseases
ES2102367T3 (es) * 1990-05-18 1997-08-01 Hoechst Ag Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
GB9115377D0 (en) * 1991-07-17 1991-09-04 Rhone Poulenc Agriculture New compositions of matter
DE4127737A1 (de) * 1991-08-22 1993-02-25 Hoechst Ag Arzneimittel zur behandlung von abstossungsreaktionen bei organverpflanzungen
GB9209330D0 (en) * 1992-04-30 1992-06-17 Roussel Lab Ltd Chemical compounds
ES2124801T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion del factor de necrosis de tumores alfa.
ES2124800T3 (es) * 1993-01-08 1999-02-16 Hoechst Ag Empleo de leflunomida para la inhibicion de interleuquina 1 beta.
DK0607777T3 (da) * 1993-01-08 1999-08-16 Hoechst Ag Anvendelse af leflunomid til inhibering af interleukin 8
TW314467B (https=) * 1993-03-31 1997-09-01 Hoechst Ag
GB9320299D0 (en) * 1993-10-01 1993-11-17 Roussel Lab Ltd Isoxazole derivatives
US5610173A (en) * 1994-01-07 1997-03-11 Sugen, Inc. Formulations for lipophilic compounds
ATE194912T1 (de) * 1994-10-17 2000-08-15 Aventis Pharma Ltd Mittel zur vorsorge und heilung von typ i allergischen krankheiten
AR001982A1 (es) * 1995-02-06 1998-01-07 Smithkline Beecham Plc Clorhidrato de paroxetina anhidratado, y procedimiento para su preparacion
DE19539638A1 (de) * 1995-10-25 1997-04-30 Hoechst Ag Die Verwendung von Isoxazol- und Crotonsäureamidderivaten zur Behandlung von Krebserkrankungen
US6316479B1 (en) * 1997-05-19 2001-11-13 Sugen, Inc. Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
HRP980291A2 (en) * 1997-06-16 1999-04-30 Lin-Hua Zhang Crystalline roxifiban
EP0903345B1 (de) * 1997-08-08 2000-10-04 Aventis Pharma Deutschland GmbH Kristallform von 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)-anilid
US6096770A (en) * 1998-08-03 2000-08-01 American Home Products Corporation Anthranilic acid analogs
DE19908527C2 (de) * 1999-02-26 2001-08-30 Aventis Pharma Gmbh Verfahren zur Kristallisation von N-(4-Trifluormethylphenyl)-5-methyl-isoxazol-4-carboxamid
CN1411373A (zh) * 1999-12-16 2003-04-16 特瓦制药工业有限公司 制备来氟米特的新方法和新晶形的来氟米特
ES2237553T3 (es) * 2000-02-15 2005-08-01 Teva Pharmaceutical Industries Ltd. Procedimiento para la sintesis de leflunomida.
US6727272B1 (en) * 2002-07-15 2004-04-27 Unitech Pharmaceuticals, Inc. Leflunomide analogs for treating rheumatoid arthritis

Similar Documents

Publication Publication Date Title
JPH11124372A5 (https=)
JP2003528100A5 (https=)
RU96121625A (ru) Стабильная кристаллическая соль тетрагидрофолиевой кислоты
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
SE8201702L (sv) Forfarande for framstellning av en cefemforening i kristalliserad form
NO126084B (https=)
JP2005536335A5 (https=)
RU99110719A (ru) Способ получения углеродметаллсодержащих наноструктур
JP2001181749A5 (https=)
RU96119320A (ru) Способ получения полиазометинов
JPS5217477A (en) Process for preparation of 1,2,3,4- tetrahydroisoquinolines and their salts
TH37167A (th) รูปสารประกอบชนิดใหม่
RU96109447A (ru) Способ получения порошка метастабильного кристаллического соединения bi2sio5
SU724510A1 (ru) Способ очистки 2,7-диаминодифениленсульфона
JPS57149244A (en) Purification of 4,4'-diphenyldicarboxylic acid
JPS5618947A (en) 2- 3-carbamoylphenyamino -n- 3,4-dimethoxyphenethyl acetamide trihydrate
UY24751A1 (es) Fabricacion del 7-bromo-5-(2-piridil)-3h-1,4-benzodiazepin-2h-ona.
JP2002520391A5 (https=)
TH29958B (th) กรรมวิธีสำหรับการทำสารประกอบให้บริสุทธิ์เชิงแสง
JPS57192376A (en) Purification of 2-mercaptothiazolines
JPS57158273A (en) Water ink
TH44061A (th) กรรมวิธีสำหรับเตรียมผลึก b -แลคแทม มอนอไฮเดรท
JPS5262287A (en) Preparation of dihydrobenzofuran derivatives
JPS5528951A (en) Crystallization of antibiotic substance
JPS5239852A (en) Heat exchange plant